Safety and Tolerability of SYNB1934 in Healthy Adult Volunteers

Authors
Category Primary study
Registry of TrialsClinicalTrials.gov
Year 2022
This Phase 1, first-in-human, multiple dose-escalation, randomized, double-blinded, placebo-controlled study is evaluating SYNB1934 in healthy volunteers (HV). Eligible subjects receive investigational product (IP) and undergo safety monitoring, evaluations, and subsequent follow-up after IP administration.
Epistemonikos ID: 802b940c42e30693fc0b31a73df3efd40fbc6887
First added on: Oct 02, 2023